Alosant Secures Major Series A Funding Led by Greg Avis, Poised for Proptech Expansion with New Leadership Appointments

Alosant, a trailblazer in customer experience technology for master-planned communities, proudly announces the completion of its Series A funding round, spearheaded by Greg Avis, co-founder and former Managing Director of Summit Partners. This pivotal development, combined with strategic leadership appointments, positions Alosant for significant growth and innovation in the proptech sector. Greg Avis, now Managing…

Read More

iOnctura Raises EUR 80 Million to Propel Groundbreaking Cancer Treatments

iOnctura, a pioneering biopharmaceutical company specializing in innovative cancer treatments, has secured EUR 80 million in Series B financing. This milestone funding round, led by Syncona Limited with participation from the European Innovation Council (EIC) Fund and existing investors, underscores iOnctura’s transformative strides in oncology. The investment will accelerate the development of iOnctura’s lead candidate,…

Read More

Attivare Therapeutics Secures $6.6 Million Grant to Advance Long-Lasting Malaria Vaccine Innovation

Attivare Therapeutics, Inc. has been awarded a $6.6 million grant from the Gates Foundation to accelerate development of a next-generation malaria vaccine designed for durability, affordability, and global accessibility. The funding supports advancement of the company’s proprietary ATTimmune™ bioscaffold platform, with a focus on populations in low- and middle-income countries where cold-chain logistics and repeat…

Read More

AI-Powered Financial Intelligence Platform 73 Strings Secures €52.7M in Series B Funding to Revolutionize Private Markets

Paris-based 73 Strings, an innovative AI-driven platform specializing in financial intelligence, has successfully raised €52.7 million ($55 million) in a Series B funding round, securing backing from some of the biggest names in finance. Goldman Sachs Alternatives’ Growth Equity, along with Blackstone Innovations Investments, led the round, with additional participation from Golub Capital, Hamilton Lane,…

Read More

Sloneek Secures €3.6M to Advance People Analytics and Expand HR Solutions Across Europe

In a significant development for the HR technology sector, Czech-Slovak startup Sloneek has announced a major funding milestone, securing €3.6 million from a consortium of prominent investors. This infusion of capital marks the largest investment to date for the rapidly growing B2B SaaS company, propelling its expansion into Western European markets. Founded with the vision…

Read More

Waypoint Bio Launches with $14.5M to Revolutionize Solid Tumor Therapy Through Innovative Drug Discovery Technology

Waypoint Bio, a pioneering biotechnology firm, has secured $14.5 million in seed funding led by Hummingbird Ventures, alongside Recode Ventures and Fifty Years, to advance its cutting-edge approach in developing cell therapies for solid tumors. Founded by MIT alumni Xinchen Wang and David Phizicky, Waypoint Bio harnesses in vivo spatial pooled screening technology to drive…

Read More

Brightflow SAS Secures €16.5M for Revolutionary Minimally Invasive Heart Failure Treatment

In a significant leap forward for cardiovascular care, Brightflow SAS has successfully raised €16.5 million in Series A funding. This impressive round of equity investment is set to propel the company’s groundbreaking efforts in developing a minimally invasive solution for end-stage heart failure. Based in France, Brightflow SAS is at the forefront of innovation in…

Read More

unspun Secures $32M in Series B Funding to Revolutionize Fashion Supply Chains with Pioneering 3D Weaving Technology

unspun, a trailblazer in 3D weaving technology, has successfully raised $32 million in an oversubscribed Series B funding round. Led by DCVC and joined by Lowercarbon Capital, E12, Decathlon, and SOSV, this funding will propel unspun’s groundbreaking technology, Vega™, to new heights. Vega™ is set to transform the fashion industry with its capability for near-zero-waste,…

Read More

Cellino Secures $25 Million Grant from ARPA-H to Revolutionize Biomanufacturing for Personalized Regenerative Medicine

In a landmark development for the field of regenerative medicine, Cellino Biotech, Inc. has been awarded up to $25 million in funding from the Advanced Research Projects Agency for Health (ARPA-H), a division within the U.S. Department of Health and Human Services. This grant will significantly advance Cellino’s NEBULA, a cutting-edge biomanufacturing technology designed to…

Read More

Appian Strengthens Executive Team with Manuel Melles as Regional VP for Central Europe

Appian (Nasdaq: APPN), a leader in process automation software, has appointed Manuel Melles as Regional Vice President (RVP) for Partners in Central Europe. Melles will spearhead Appian’s efforts to expand partnerships and drive business growth across Germany, Austria, Switzerland (DACH), and France, focusing on delivering transformative process automation solutions to customers. With over 20 years…

Read More